Theranostics Health Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Theranostics Health Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013205
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Theranostics Health Inc (Theranostics), a subsidiary of Avant Diagnostics Inc is a healthcare service provider that offers protein based solutions. The company provides protein based discovery and translational research services. Its products include molecular navigation of targeted therapies, laser capture micro dissection, pre-analytical sample handling, biological samples, and reverse-phase protein microarray. Theranostics concentrates on the quantitative measurement of proteins comprising key signaling pathways in disease and includes pre-analytical processing of preclinical and clinical samples, LCM, and RPMA. The company’s services include proteomics services, custom services and bioinformatic services. It serves drug development companies and academic institutions. Theranostics is headquartered in Gaithersburg, Maryland, the US.

Theranostics Health Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Theranostics Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Theranostics Health Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Theranostics Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Theranostics Health Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Theranostics Health Inc, Medical Devices Deals, 2011 to YTD 2017 9
Theranostics Health Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Theranostics Health Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Theranostics Health Raises USD0.2 Million in Financing Round 11
Theranostics Health Raises US$0.2 Million In Venture Financing 12
Theranostics Health Raises US$1 Million In Venture Financing 13
Theranostics Health Raises US$0.04 Million In Venture Financing 14
Theranostics Health Secures US$1.52 Million In Venture Financing 15
Licensing Agreements 16
Theranostics Health Enters into Licensing Agreement with Grace Bio-Labs 16
Acquisition 17
Avant Diagnostics Acquires Theranostics Health 17
Theranostics Health Inc – Key Competitors 18
Theranostics Health Inc – Key Employees 19
Theranostics Health Inc – Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Theranostics Health Inc, Pharmaceuticals & Healthcare, Key Facts 2
Theranostics Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Theranostics Health Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Theranostics Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Theranostics Health Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Theranostics Health Inc, Medical Devices Deals, 2011 to YTD 2017 9
Theranostics Health Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Theranostics Health Raises USD0.2 Million in Financing Round 11
Theranostics Health Raises US$0.2 Million In Venture Financing 12
Theranostics Health Raises US$1 Million In Venture Financing 13
Theranostics Health Raises US$0.04 Million In Venture Financing 14
Theranostics Health Secures US$1.52 Million In Venture Financing 15
Theranostics Health Enters into Licensing Agreement with Grace Bio-Labs 16
Avant Diagnostics Acquires Theranostics Health 17
Theranostics Health Inc, Key Competitors 18
Theranostics Health Inc, Key Employees 19

★海外企業調査レポート[Theranostics Health Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cancer Research Technology Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Cancer Research Technology Ltd (CRT), formerly Cancer Research Campaign Technology Ltd, a subsidiary of Cancer Research UK, is a research organization that develops and commercializes discoveries for treatment in the areas of cancer. The organization offers services such as project developme …
  • Canadian Tire Corp Ltd (CTC.A):企業の財務・戦略的SWOT分析
    Canadian Tire Corp Ltd (CTC.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Takara Bio Inc (4974)-医療機器分野:企業M&A・提携分析
    Summary Takara Bio Inc (Takara), a subsidiary of Takara Holdings Inc is a biotechnology company that develops, manufactures and distributes biotechnology research reagents and equipments. The company sells gene amplification system and offers scientific instruments. Takara also provides contract res …
  • Stilo International Plc (STL):企業の財務・戦略的SWOT分析
    Summary Stilo International plc (Stilo) operates as a technology company that offers cloud content solutions. The company’s products include developer tools, XML cloud conversion and SME authoring. It offers digital content and publishes information to multiple channels such as print, web, CD-ROM, s …
  • Berner Oberland-Bahnen AG:企業の戦略・SWOT・財務情報
    Berner Oberland-Bahnen AG - Strategy, SWOT and Corporate Finance Report Summary Berner Oberland-Bahnen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Aeon Delight Co Ltd:企業の戦略・SWOT・財務情報
    Aeon Delight Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Aeon Delight Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Applied Industrial Technologies Inc (AIT):石油・ガス:M&Aディール及び事業提携情報
    Summary Applied Industrial Technologies Inc. (Applied Industrial) is a distributor of industrial products and services to MRO and OEM customers. The company also provides engineering, design and systems integration services for industrial and fluid power applications, besides tailored mechanical, fa …
  • Intermountain Healthcare Inc-医療機器分野:企業M&A・提携分析
    Summary Intermountain Healthcare Inc (Intermountain Healthcare) is a non-profit health care system. It provides health care services to Utah and Southeastern Idaho residents. It offers a wide range of clinical programs covering cardiovascular, intensive medicine, primary care, pediatric specialties, …
  • The Carlyle Group LP (CG):企業の財務・戦略的SWOT分析
    The Carlyle Group LP (CG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • WABCO Holdings Inc.:企業の戦略・SWOT・財務情報
    WABCO Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary WABCO Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Metso Corp (METSO):電力:M&Aディール及び事業提携情報
    Summary Metso Corp (Metso) is an industrial machinery company that provides sustainable technology and services. It offers products such as mining and construction aggregates processing equipments, conveyers, separators, air classifiers, slurry pumps, industrial valves and controls, and waste shredd …
  • Valener Inc (VNR)-石油・ガス分野:企業M&A・提携分析
    Summary Valener Inc (Valener) is an investment holding company that focuses on the energy sector. Through its investment companies, the company offers storage, distribution, transportation and allied energy services. The company has interests in Gaz Metro and is its limited partner. Valener, through …
  • CymaBay Therapeutics Inc (CBAY):製薬・医療:M&Aディール及び事業提携情報
    Summary CymaBay Therapeutics Inc (CymaBay), formerly Metabolex Inc is a clinical-stage biopharmaceutical company that develops therapeutics to treat diabetes, orphan diseases and related metabolic disorders. The company’s pipeline products comprise Arhalofenate, an oral small molecule intended for t …
  • Underwriters Laboratories Inc.:企業のM&A・事業提携・投資動向
    Underwriters Laboratories Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Underwriters Laboratories Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Peabody Energy Corporation:企業のM&A・事業提携・投資動向
    Peabody Energy Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Peabody Energy Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Aeglea BioTherapeutics Inc (AGLE):企業の財務・戦略的SWOT分析
    Summary Aeglea BioTherapeutics Inc (Aeglea), formerly Aeglea BioTherapeutics Holdings, LLC is a biotechnology company. The company develops and commercializes human enzymes for the treatment of cancer and rare genetic diseases. The company’s lead product pipeline includes pegzilarginase (AEB1102), i …
  • Banco de Sabadell SA:企業の戦略・SWOT・財務情報
    Banco de Sabadell SA - Strategy, SWOT and Corporate Finance Report Summary Banco de Sabadell SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Newfield Exploration Company (NFX):石油・ガス:M&Aディール及び事業提携情報
    Summary Newfield Exploration Co (Newfield) is an independent upstream company. The company focuses on onshore large scale, liquids-rich resource plays. Its domestic assets are in the Anadarko and Arkoma basins of Oklahoma, the Williston Basin of North Dakota and the Uinta Basin of Utah. The company …
  • WNDM Medical Inc (WNDM):製薬・医療:M&Aディール及び事業提携情報
    Summary WNDM Medical Inc (WNDM Medical), formerly Wound Management Technologies Inc is a distributor of biotechnology products to hospitals, physicians, and clinics. The company offers its patented product CellerateRX in powder and gel forms, and hemaquell resorbable bone wax that controls bone blee …
  • Ascletis Inc-製薬・医療分野:企業M&A・提携分析
    Summary Ascletis Inc (Ascletis) is a healthcare company that provides therapeutics for cancer and infectious diseases. The company offers discovery, demonstration of global partnering, clinical proof-of-concept, and research and development services of novel therapeutics for life-threatening disease …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆